Non-Canonical Role for the TRAIL Receptor DR5/FADD/Caspase Pathway in the Regulation of MyoD Expression and Skeletal Myoblast Differentiation
We report herein that the TRAIL receptor DR5/FADD/caspase pathway plays a role in skeletal myoblast differentiation through modulation of the expression of the muscle regulatory transcription factor MyoD. Specifically, treatment with the selective caspase 3 inhibitor DEVD-fmk or the selective caspase 8 inhibitor IETD-fmk in growth media (GM), prior to culture in differentiation media (DM), inhibited differentiation. Further, this treatment resulted in decreased levels of MyoD message and protein. We next explored a role for the TRAIL receptor DR5/FADD pathway. We found that expression of either dominant negative (dn) FADD or dominant negative (dn) DR5 also resulted in decreased levels of MyoD mRNA and protein and blocked differentiation. This decreased level of MyoD mRNA was not a consequence of altered stability. Treatment with TSA, an inhibitor of histone deacetylases (HDACs), allowed MyoD expression in myoblasts expressing dnDR5. Finally, acetylation of histones associated with the distal regulatory region (DRR) enhancer of MyoD was decreased in myoblasts expressing dnDR5. Thus, our data suggests a non-canonical role for the TRAIL receptor/FADD pathway in the regulation of MyoD expression and skeletal myoblast differentiation. © 2009 International Society of Differentiation.
Freer-Prokop, Margot; O'Flaherty, John; Ross, Jason A.; and Weyman, Crystal M., "Non-Canonical Role for the TRAIL Receptor DR5/FADD/Caspase Pathway in the Regulation of MyoD Expression and Skeletal Myoblast Differentiation" (2009). Biological, Geological, and Environmental Faculty Publications. 172.